Alan Rigby

Alan Rigby Email and Phone Number

CEO, C-level Entrepreneur, Oncology Innovator, Founder, Visionary Team Builder @ Epitopea
Alan Rigby's Location
New York, New York, United States, United States
Alan Rigby's Contact Details

Alan Rigby personal email

n/a
About Alan Rigby

"Visionary entrepreneur focused on moving molecules from ideation into the clinic trials"Oncology Drug Discovery Innovation that leverages deep machine learning to annotate patient geneticsAntibody & Small Molecule Drug ConjugatesStructure-based Computational Drug Discovery Structural BiologyAcademic/ Pharma/ Biotechnology InterfaceAccelerating Drug Discovery

Alan Rigby's Current Company Details
Epitopea

Epitopea

View
CEO, C-level Entrepreneur, Oncology Innovator, Founder, Visionary Team Builder
Alan Rigby Work Experience Details
  • Epitopea
    Chief Executive Officer
    Epitopea Nov 2023 - Present
    Montreal, Ca
    At Epitopea we know that better cancer therapies are needed to transform patient responses and their lives. Epitopea is the global leader in exploiting a novel class of untapped, aberrantly expressed tumor-specific antigens (aeTSAs) or CryptigenTM TSAs that are shared across multiple patients with the same tumor type. We leverage these differentiated aeTSAs to rapidly advance the development of accessible, off-the-shelf cancer RNA immunotherapies that we believe will significantly impact patients’ lives.
    View
  • Acr Biotechnology Consultants, Llc
    President
    Acr Biotechnology Consultants, Llc Dec 2017 - Present
  • Hibercell
    Senior Board Advisor
    Hibercell Jun 2022 - Jul 2024
    New York, New York, Us
    View
  • Hibercell
    President And Chief Executive Officer
    Hibercell Sep 2019 - Jun 2022
    New York, New York, Us
    View
  • Hibercell
    Co-Founder, President And Chief Scientific Officer
    Hibercell Jan 2018 - Jun 2022
    New York, New York, Us
    HiberCell is 'The Tumor Dormancy Company' with a focus on targeting dormant disseminated tumor cells to prevent or delay cancer relapse and metastasis.
    View
  • Exarta Therapeutics
    Chief Executive Officer And President
    Exarta Therapeutics Jan 2023 - Oct 2023
    At Exarta I worked closely with pioneering academic founders, Drs. Brent Stockwell and Xuejun Jiang to help build and validate transformative medicines that modulate the biology of ferroptosis and in doing so course correct the pathogenesis of cancer resistance and neurodegenerative disease.
  • Warp Drive Bio, Inc.
    Chief Scientific Officer
    Warp Drive Bio, Inc. Apr 2016 - Dec 2017
  • Synta Pharmaceuticals
    Chief Scientific Officer, Senior Vice President
    Synta Pharmaceuticals Aug 2015 - Feb 2016
  • Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company
    Vice President Of Antibody Drug Conjugate Biology
    Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company Feb 2014 - Aug 2015
    Us
    View
  • Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company
    Vice President Research- Computational Discovery & Chemistry
    Imclone Systems, A Wholly-Owned Subsidiary Of Eli Lilly And Company Oct 2010 - Jan 2014
    Us
    View
  • Harvard Medical School
    Adjunct Assistant Professor
    Harvard Medical School Oct 2010 - Feb 2012
    Boston, Ma, Us
    Director of Drug Discovery & Target Validation Program
    View
  • Harvard Medical School
    Assistant Professor
    Harvard Medical School Nov 2001 - Oct 2010
    Boston, Ma, Us
    View
  • Beth Israel Deaconess Medical Center
    Adjunct Director Of Drug Discovery And Target Validation
    Beth Israel Deaconess Medical Center Jul 2010 - Feb 2012
    Boston, Ma, Us
    Accelerating Discovery in the Center for Vascular Biology
    View
  • Beth Israel Deaconess Medical Center
    Director Program In Drug Discovery & Target Validation
    Beth Israel Deaconess Medical Center Apr 2008 - Oct 2010
    Boston, Ma, Us
    View
  • Karyon Therapeutics
    Co-Founder, Sab Member
    Karyon Therapeutics Nov 2009 - Jan 2012
    NewCo opportunity
  • Vasculomedics
    Co-Founder, Consultant
    Vasculomedics Nov 2007 - Feb 2009
  • Harvard Medical School
    Instructor Of Medicine
    Harvard Medical School 1998 - 2001
    Boston, Ma, Us
    View

Alan Rigby Skills

Drug Discovery Oncology Life Sciences Biochemistry Biotechnology Computational Chemistry Antibodies Target Identification Validation Academia Molecular Biology Biomarker Discovery Immunology Chemistry Structural Biology Protein Chemistry Pharmaceutical Industry Nmr Drug Development Clinical Development Innovator Clinical Trials

Alan Rigby Education Details

  • Western University
    Western University
    Biochemistry

Frequently Asked Questions about Alan Rigby

What company does Alan Rigby work for?

Alan Rigby works for Epitopea

What is Alan Rigby's role at the current company?

Alan Rigby's current role is CEO, C-level Entrepreneur, Oncology Innovator, Founder, Visionary Team Builder.

What is Alan Rigby's email address?

Alan Rigby's email address is ar****@****bio.com

What schools did Alan Rigby attend?

Alan Rigby attended Western University.

What skills is Alan Rigby known for?

Alan Rigby has skills like Drug Discovery, Oncology, Life Sciences, Biochemistry, Biotechnology, Computational Chemistry, Antibodies, Target Identification, Validation, Academia, Molecular Biology, Biomarker Discovery.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.